These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 1660689)
1. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas. Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689 [TBL] [Abstract][Full Text] [Related]
2. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance. Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression. Spaventi R; Kamenjicki E; Pecina N; Grazio S; Grazio S; Pavelic J; Kusic B; Cvrtila D; Danilovic Z; Spaventi S In Vivo; 1994; 8(2):183-9. PubMed ID: 7919121 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of c-myc proto-oncogene in primary human breast carcinomas. Pavelic ZP; Steele P; Preisler HD Anticancer Res; 1991; 11(4):1421-7. PubMed ID: 1660688 [TBL] [Abstract][Full Text] [Related]
5. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors. Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes. Pechoux C; Chardonnet Y; Chignol MC; Noël P Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818 [TBL] [Abstract][Full Text] [Related]
7. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer. Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023 [TBL] [Abstract][Full Text] [Related]
8. [Gallbladder carcinoma: expression of the c-myc and ras-p-21 oncogene products]. Roa I; Araya JC; Shiraishi T; Yatani R; Wistuba I; Villaseca M; de Aretxabala X Rev Med Chil; 1994 Jul; 122(7):754-9. PubMed ID: 7732224 [TBL] [Abstract][Full Text] [Related]
9. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis. Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488 [TBL] [Abstract][Full Text] [Related]
10. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues. Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues. Mizukami Y; Nonomura A; Yamada T; Kurumaya H; Hayashi M; Koyasaki N; Taniya T; Noguchi M; Nakamura S; Matsubara F Anticancer Res; 1990; 10(5A):1115-26. PubMed ID: 1978632 [TBL] [Abstract][Full Text] [Related]
12. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras. Volm M; Mattern J Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109 [TBL] [Abstract][Full Text] [Related]
13. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis. Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the ras and myc oncoproteins in benign gastric lesions. Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK; Spandidos DA Anticancer Res; 1990; 10(5A):1127-33. PubMed ID: 2241094 [TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization. Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216 [TBL] [Abstract][Full Text] [Related]
17. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease. Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926 [TBL] [Abstract][Full Text] [Related]
18. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction. Naidu R; Wahab NA; Yadav M; Kutty MK Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932 [TBL] [Abstract][Full Text] [Related]
19. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung. Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469 [TBL] [Abstract][Full Text] [Related]
20. Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi's sarcoma. Spandidos DA; Kaloterakis A; Yiagnisis M; Varatsos A; Field JK Anticancer Res; 1990; 10(6):1619-25. PubMed ID: 1980998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]